Volume 28, Number 6—June 2022
Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014–2016
||Societal perspective, medical cost per participant,* 2016 US dollars
*Societal medical cost per participant excludes Current Procedural Terminology (CPT) codes deemed unrelated to Lyme disease as determined by a physician subject matter expert (Appendix Table 5). †Estimates for the overall population use the sample-weighted data except the range.